-
1
-
-
0026655937
-
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro
-
Barbas CF, III, et al. 1992. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U. S. A. 89:9339-9343.
-
(1992)
Proc. Natl. Acad. Sci. U. S. A.
, vol.89
, pp. 9339-9343
-
-
Barbas III, C.F.1
-
2
-
-
56449131391
-
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
-
Binley JM, et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J. Virol. 82:11651-11668.
-
(2008)
J. Virol.
, vol.82
, pp. 11651-11668
-
-
Binley, J.M.1
-
3
-
-
80052938385
-
Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors
-
Bonsignori M, et al. 2011. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 85:9998-10009.
-
(2011)
J. Virol.
, vol.85
, pp. 9998-10009
-
-
Bonsignori, M.1
-
4
-
-
84860723906
-
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design
-
Bonsignori M, et al. 2012. Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design. J. Virol. 86:4688-4692.
-
(2012)
J. Virol.
, vol.86
, pp. 4688-4692
-
-
Bonsignori, M.1
-
5
-
-
0027985431
-
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
-
Burton DR, et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266: 1024-1027.
-
(1994)
Science
, vol.266
, pp. 1024-1027
-
-
Burton, D.R.1
-
6
-
-
13844255333
-
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
-
Cardoso RM, et al. 2005. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22:163-173.
-
(2005)
Immunity
, vol.22
, pp. 163-173
-
-
Cardoso, R.M.1
-
7
-
-
77649318846
-
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
-
doi:10.1371/journal-.pone.0008805
-
Corti D, et al. 2010. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One 5:e8805. doi:10.1371/journal-.pone.0008805.
-
(2010)
PLoS One
, vol.5
-
-
Corti, D.1
-
8
-
-
67249085575
-
Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site
-
doi:10.1371/journal.ppat.1000445
-
Dey B, et al. 2009. Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site. PLoS Pathog. 5:e1000445. doi:10.1371/journal.ppat.1000445.
-
(2009)
PLoS Pathog
, vol.5
-
-
Dey, B.1
-
9
-
-
82755184131
-
Increasing the potency and breadth of an HIV antibody by using structure-based rational design
-
Diskin R, et al. 2011. Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334:1289-1293.
-
(2011)
Science
, vol.334
, pp. 1289-1293
-
-
Diskin, R.1
-
10
-
-
77749306129
-
Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression
-
Euler Z, et al. 2010. Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression. J. Infect. Dis. 201:1045-1053.
-
(2010)
J. Infect. Dis.
, vol.201
, pp. 1045-1053
-
-
Euler, Z.1
-
11
-
-
0041828179
-
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
-
Fiebig EW, et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
-
(2003)
AIDS
, vol.17
, pp. 1871-1879
-
-
Fiebig, E.W.1
-
12
-
-
67449147145
-
The first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection
-
Goonetilleke N, et al. 2009. The first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1253-1272.
-
(2009)
J. Exp. Med.
, vol.206
, pp. 1253-1272
-
-
Goonetilleke, N.1
-
13
-
-
79955389756
-
The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+T cell decline and high viral load during acute infection
-
Gray ES, et al. 2011. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+T cell decline and high viral load during acute infection. J. Virol. 85:4828-4840.
-
(2011)
J. Virol.
, vol.85
, pp. 4828-4840
-
-
Gray, E.S.1
-
14
-
-
69249208675
-
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors
-
Gray ES, et al. 2009. Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. J. Virol. 83:8925-8937.
-
(2009)
J. Virol.
, vol.83
, pp. 8925-8937
-
-
Gray, E.S.1
-
15
-
-
0034482696
-
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates
-
Kwong PD, et al. 2000. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure 8:1329-1339.
-
(2000)
Structure
, vol.8
, pp. 1329-1339
-
-
Kwong, P.D.1
-
16
-
-
34948854718
-
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
-
Li Y, et al. 2007. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat. Med. 13:1032-1034.
-
(2007)
Nat. Med.
, vol.13
, pp. 1032-1034
-
-
Li, Y.1
-
17
-
-
58149517700
-
Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals
-
Li Y, et al. 2009. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. J. Virol. 83:1045-1059.
-
(2009)
J. Virol.
, vol.83
, pp. 1045-1059
-
-
Li, Y.1
-
18
-
-
80055115342
-
Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection
-
Liu P, et al. 2011. Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J. Virol. 85:11196-11207.
-
(2011)
J. Virol.
, vol.85
, pp. 11196-11207
-
-
Liu, P.1
-
19
-
-
83455254775
-
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
-
McLellan JS, et al. 2011. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480:336-343.
-
(2011)
Nature
, vol.480
, pp. 336-343
-
-
McLellan, J.S.1
-
20
-
-
72949117233
-
The immune response during acute HIV-1 infection: clues for vaccine development
-
McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10:11-23.
-
(2010)
Nat. Rev. Immunol.
, vol.10
, pp. 11-23
-
-
McMichael, A.J.1
Borrow, P.2
Tomaras, G.D.3
Goonetilleke, N.4
Haynes, B.F.5
-
21
-
-
79551518897
-
Characteristics of the earliest cross-neutralizing antibody response to HIV-1
-
doi:10.1371/ journal.ppat.1001251
-
Mikell I, et al. 2011. Characteristics of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog. 7:e1001251. doi:10.1371/ journal.ppat.1001251.
-
(2011)
PLoS Pathog
, vol.7
-
-
Mikell, I.1
-
22
-
-
0027397052
-
Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans
-
Moore JP, Ho DD. 1993. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:863-875.
-
(1993)
J. Virol.
, vol.67
, pp. 863-875
-
-
Moore, J.P.1
Ho, D.D.2
-
23
-
-
80053584837
-
Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting
-
doi:10.1371/journal.pone.0023532
-
Morris L, et al. 2011. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One 6:e23532. doi:10.1371/journal.pone.0023532.
-
(2011)
PLoS One
, vol.6
-
-
Morris, L.1
-
24
-
-
4544379899
-
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
-
Ofek G, et al. 2004. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78:10724-10737.
-
(2004)
J. Virol.
, vol.78
, pp. 10724-10737
-
-
Ofek, G.1
-
25
-
-
82255179322
-
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield
-
Pejchal R, et al. 2011. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334:1097-1103.
-
(2011)
Science
, vol.334
, pp. 1097-1103
-
-
Pejchal, R.1
-
26
-
-
70349298392
-
Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression
-
Piantadosi A, et al. 2009. Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression. J. Virol. 83:10269-10274.
-
(2009)
J. Virol.
, vol.83
, pp. 10269-10274
-
-
Piantadosi, A.1
-
27
-
-
0027458347
-
Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120
-
Posner MR, Cavacini LA, Emes CL, Power J, Byrn R. 1993. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquir. Immune Defic. Syndr. 6:7-14.
-
(1993)
J. Acquir. Immune Defic. Syndr.
, vol.6
, pp. 7-14
-
-
Posner, M.R.1
Cavacini, L.A.2
Emes, C.L.3
Power, J.4
Byrn, R.5
-
28
-
-
58149487645
-
Factors associated with the development of crossreactive neutralizing antibodies during human immunodeficiency virus type 1 infection
-
Sather DN, et al. 2009. Factors associated with the development of crossreactive neutralizing antibodies during human immunodeficiency virus type 1 infection. J. Virol. 83:757-769.
-
(2009)
J. Virol.
, vol.83
, pp. 757-769
-
-
Sather, D.N.1
-
29
-
-
80052925616
-
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding
-
Scheid JF, et al. 2011. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333:1633-1637.
-
(2011)
Science
, vol.333
, pp. 1633-1637
-
-
Scheid, J.F.1
-
30
-
-
0027256814
-
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
-
Thali M, et al. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
-
(1993)
J. Virol.
, vol.67
, pp. 3978-3988
-
-
Thali, M.1
-
31
-
-
0026085170
-
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
-
Thali M, et al. 1991. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65:6188-6193.
-
(1991)
J. Virol.
, vol.65
, pp. 6188-6193
-
-
Thali, M.1
-
32
-
-
80055104586
-
Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals
-
Tomaras GD, et al. 2011. Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals. J. Virol. 85:11502-11519.
-
(2011)
J. Virol.
, vol.85
, pp. 11502-11519
-
-
Tomaras, G.D.1
-
33
-
-
57349127300
-
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia
-
Tomaras GD, et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
-
(2008)
J. Virol.
, vol.82
, pp. 12449-12463
-
-
Tomaras, G.D.1
-
34
-
-
9044241681
-
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
-
Trkola A, et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
-
(1996)
J. Virol.
, vol.70
, pp. 1100-1108
-
-
Trkola, A.1
-
35
-
-
80053132436
-
Broad neutralization coverage of HIV by multiple highly potent antibodies
-
Walker LM, et al. 2011. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477:466-470.
-
(2011)
Nature
, vol.477
, pp. 466-470
-
-
Walker, L.M.1
-
36
-
-
70349887757
-
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
-
Walker LM, et al. 2009. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285-289.
-
(2009)
Science
, vol.326
, pp. 285-289
-
-
Walker, L.M.1
-
37
-
-
77958115264
-
A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
-
doi:10.1371/journal.ppat.1001028
-
Walker LM, et al. 2010. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog. 6:e1001028. doi:10.1371/journal.ppat.1001028.
-
(2010)
PLoS Pathog
, vol.6
-
-
Walker, L.M.1
-
38
-
-
0036090585
-
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
-
Wei X, et al. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 1896-1905
-
-
Wei, X.1
-
39
-
-
77954920017
-
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
-
Wu X, et al. 2010. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329:856-861.
-
(2010)
Science
, vol.329
, pp. 856-861
-
-
Wu, X.1
-
40
-
-
70350320690
-
Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment
-
Wu X, et al. 2009. Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment. J. Virol. 83:10892-10907.
-
(2009)
J. Virol.
, vol.83
, pp. 10892-10907
-
-
Wu, X.1
-
41
-
-
80052942203
-
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing
-
Wu X, et al. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333:1593-1602.
-
(2011)
Science
, vol.333
, pp. 1593-1602
-
-
Wu, X.1
-
42
-
-
0032543555
-
The antigenic structure of the HIV gp120 envelope glycoprotein
-
Wyatt R, et al. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711.
-
(1998)
Nature
, vol.393
, pp. 705-711
-
-
Wyatt, R.1
-
43
-
-
10744226328
-
Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library
-
Zhang MY, et al. 2003. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. J. Immunol. Methods 283:17-25.
-
(2003)
J. Immunol. Methods
, vol.283
, pp. 17-25
-
-
Zhang, M.Y.1
-
44
-
-
77954943648
-
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01
-
Zhou T, et al. 2010. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329:811-817.
-
(2010)
Science
, vol.329
, pp. 811-817
-
-
Zhou, T.1
-
45
-
-
33847101745
-
Structural definition of a conserved neutralization epitope on HIV-1 gp120
-
Zhou T, et al. 2007. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445:732-737.
-
(2007)
Nature
, vol.445
, pp. 732-737
-
-
Zhou, T.1
|